Justin Lygrisse

Justin Lygrisse

Justin Lygrisse is the Director of Research & Development (R&D) for the Nasal Spray business unit at Kindeva Drug Delivery. He received a Bachelor’s and Master’s degree in Chemistry from Wichita State University in 2005 and 2009 respectively. He has been a researcher in the fields of analytical chemistry and drug development for more than 20 years. In his current capacity as Director of R&D, he leads nasal spray drug product development for Kindeva Drug Delivery.

  • Intranasal,Or,Nasal,Spray,Vaccine,Against,The,Coronavirus,That,Causes
    Article

    Nasal drug delivery: the non-invasive future of treatment

    2025-11-10T09:00:00

    Advances in formulation science and device technology are transforming nasal drug delivery, enhancing absorption, stability and patient adherence. This article examines the innovations driving its growth and highlights future applications ranging from systemic treatments to nose-to-brain therapies and vaccines.